TheUniversityofKentucky(UK)CenterforClinicalandTranslationalScience(CCTS)hascreatedan integratedhomeforclinicalandtranslationalresearchtopromotescientificprogressanddiscoveriesatevery phaseofthetranslationalcontinuum.TheCCTShasfundamentallytransformedtheresearchenvironmentnot onlyatUKbutthroughoutCentralAppalachiathroughthedevelopmentofastrongresearchnetwork,the AppalachianTranslationalResearchNetwork(ATRN),withintegratedresearchpartnershipsincludingother CTSAhubs.Whencombinedwithanin-depthunderstandingoftheuniqueandserioushealthchallenges facedbyCentralAppalachianresidents,theUKCCTSispositionedtoleadlocal,regionalandnational researcheffortsthatfocusonthesignificanthealthdisparitiesinthispopulation.Ouroverarchinggoalasa CTSAhubistocontinuetochampioninnovationinthefullspectrumofclinicalandtranslationalresearchwhile educatingtheworkforceofthefuture,engagingourcommunitiesinbiomedicalscienceandworkingwiththe nationalnetworktoadvancecohesivemulti-centerclinicaltrials,whichwillultimatelyelevatethehealthand qualityoflifeofthepopulaceofCentralAppalachia.Specifically,theUKCCTSwill:1)Leadinstitutional innovationinthedeliveryofefficient,effectiveclinicalandtranslationalresearch.2)Developadiverse workforceacrossmultipledisciplinesthatadvancestranslationalresearchandexcelsinteam-basedscience. 3)MeettheuniqueneedsofCentralAppalachianresidentsbyextensivelyengagingandcollaboratingwithour regional,ruralandcommunity-basedpartners.4)Catalyzeinnovativeresearch,includingnoveldrug developmentandinformaticsmethodologies,withparticularfocusonbringinginnovationtospecialpopulations andacrossthelifespan.5)Createanefficientclinicaltrialsnetwork,centeredatUK,andextendingintoour partnerhealthcaresystemsthatwillbeanessentialandleadingcomponentoftheCTSAconsortium,involving participantsthroughoutafourstateregionofruralCentralAppalachia.TheUKCCTSbenefitsfroma collaborativeenvironmentfoundononlyafewuniversitycampuses.UKhas16colleges,with11involvedin theUKCCTS(includingsixbiomedicalcolleges)ononecentralcampus.Thisphysicalproximityofour academicandhealthcarecommunities,alongwithacultureofcollaboration,createsacloselyknitunified academiccommunityandpositionstheUKCCTStodemonstratetheimpactofcollaborativetranslational researchandleadershipinteamscience.Oureffortshavealreadybeensuccessfulattransformingtheculture oftheUKacademicmedicalcentertoonethatmorekeenlyappreciatesscholarship,innovationand translationalscience.Wenowplantobuildonthesestrengthstoadvancetranslationalsciencetothenext level,withfurtherdevelopmentofourclinicaltrialnetworks,developmentofnovelinformaticsprograms,and continueddevelopmentoftheworkforcethroughouttheregion.Theseeffortswillbenefitthemedically underservedresidentsofCentralAppalachiaandwillsignificantlycontributetothenationalCTSAprogram. 1 Project Summary/Abstract Page 287 Contact PD/PI: Kern, Philip A

Public Health Relevance

The University of Kentucky (UK) Center for Clinical and Translational Science (CCTS) is strategically positioned in Central Appalachia to catalyze efforts to connect the populace of this medically underserved region, with significant health disparities, to the national CTSA network. The UK CCTS is recognized locally and regionally for affecting change and building robust partnerships across the CTSA network, in Central Appalachia and at UK, creating an efficient platform for clinical and translational research and training, all to improve quality of care, health, and well-being for the rural populations of this region. 1 Project Narrative Page 288

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
1UL1TR001998-01
Application #
9314011
Study Section
Special Emphasis Panel (ZTR1-SRC (99))
Program Officer
Brazhnik, Olga
Project Start
2016-08-15
Project End
2020-05-31
Budget Start
2016-08-15
Budget End
2017-05-31
Support Year
1
Fiscal Year
2016
Total Cost
$3,645,338
Indirect Cost
$1,174,472
Name
University of Kentucky
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Rotroff, Daniel M; Pijut, Sonja S; Marvel, Skylar W et al. (2018) Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes. Clin Pharmacol Ther 103:712-721
Kosmac, Kate; Peck, Bailey D; Walton, R Grace et al. (2018) Immunohistochemical Identification of Human Skeletal Muscle Macrophages. Bio Protoc 8:
Lee, Na-Ra; Zheng, Guangrong; Crooks, Peter A et al. (2018) New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders. AAPS J 20:29
Savi, Daiani C; Shaaban, Khaled A; Gos, Francielly Maria Wilke Ramos et al. (2018) Phaeophleospora vochysiae Savi & Glienke sp. nov. Isolated from Vochysia divergens Found in the Pantanal, Brazil, Produces Bioactive Secondary Metabolites. Sci Rep 8:3122
Zhang, Xiaofei; Zhang, Yi; Han, Erik Y et al. (2018) Classification of Whole Mammogram and Tomosynthesis Images Using Deep Convolutional Neural Networks. IEEE Trans Nanobioscience 17:237-242
El-Husseini, Amr; Saleh, Sherif; Hamad, Omer et al. (2018) Outcome of Patients With Small Vessel Vasculitis After Renal Transplantation: National Database Analysis. Transplant Direct 4:e350
Chen, Xi; Smelter, Andrey; Moseley, Hunter N B (2018) Automatic 13C chemical shift reference correction for unassigned protein NMR spectra. J Biomol NMR 72:11-28
Wesley, Michael J; Westgate, Philip M; Stoops, William W et al. (2018) Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users. Exp Clin Psychopharmacol 26:310-319
Salt, Elizabeth; Wiggins, Amanda T; Rayens, Mary Kay et al. (2018) Risk Factors for Transfusions Following Total Joint Arthroplasty in Patients With Rheumatoid Arthritis. J Clin Rheumatol 24:422-426
Niederer, Steven A; Campbell, Kenneth S; Campbell, Stuart G (2018) A short history of the development of mathematical models of cardiac mechanics. J Mol Cell Cardiol 127:11-19

Showing the most recent 10 out of 293 publications